Published in Cancer Gene Ther on May 24, 2013
EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMA. Drugs Future (2016) 0.84
Predicting and optimizing the territory of blood-brain barrier opening by superselective intra-arterial cerebral infusion under dynamic susceptibility contrast MRI guidance. J Cereb Blood Flow Metab (2015) 0.82
MicroRNA 142-3p attenuates spread of replicating retroviral vector in hematopoietic lineage-derived cells while maintaining an antiviral immune response. Hum Gene Ther (2014) 0.80
Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice. Mol Neurodegener (2016) 0.79
Convection enhanced delivery of cisplatin-loaded brain penetrating nanoparticles cures malignant glioma in rats. J Control Release (2017) 0.77
Brain tumors. N Engl J Med (2001) 8.13
Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A (1994) 6.61
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med (2003) 4.51
Glioblastoma multiforme: the terminator. Proc Natl Acad Sci U S A (2000) 3.69
Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Exp Neurol (2000) 2.98
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology (2008) 2.80
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol (2003) 2.63
Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg (1998) 2.13
Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res (2004) 2.10
The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. Mol Ther (2006) 2.10
Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res (2001) 2.06
Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics (2008) 1.79
Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Exp Neurol (2005) 1.78
Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. Brain Res Brain Res Protoc (2005) 1.74
Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease. Hum Gene Ther (2012) 1.70
Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies. Acta Neurochir Suppl (2003) 1.51
Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs (2000) 1.42
Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain. Stereotact Funct Neurosurg (2011) 1.30
Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model. Cancer Res (2004) 1.26
Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma. Mol Ther (2005) 1.25
Optimized cannula design and placement for convection-enhanced delivery in rat striatum. J Neurosci Methods (2009) 1.25
Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates. Neuroimage (2009) 1.24
Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector. Neuro Oncol (2011) 1.22
Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer (2004) 1.19
Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression. Mol Ther (2012) 1.05
Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model. Neurosurg Focus (2006) 0.99
Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics. J Neurosurg (2010) 0.99
Type I IFNs signaling and apoptosis resistance in glioblastoma cells. Apoptosis (2011) 0.93
The role of chemotherapy in recurrent malignant gliomas: an overview. Cancer Invest (1996) 0.92
Gene and cell delivery to the degenerated striatum: status of preclinical efforts in primate models. Neurosurgery (2008) 0.90
Effects of 5-FU. Adv Exp Med Biol (2010) 0.88
Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. Neurosurgery (1996) 0.85
Development of microspheres for neurological disorders: from basics to clinical applications. J Control Release (2000) 0.85
Tumoricidal bystander effect in the suicide gene therapy using mesenchymal stem cells does not injure normal brain tissues. Cancer Lett (2011) 0.81
Therapeutic effectiveness of novel 5-fluorouracil-loaded poly(methylidene malonate 2.1.2)-based microspheres on F98 glioma-bearing rats. Cancer (2003) 0.81
Phase I/II study of cisplatin, 5-fluorouracil and alpha-interferon for recurrent carcinoma of the head and neck. Invest New Drugs (1994) 0.77
High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet (1998) 21.52
Base sequence studies of 300 nucleotide renatured repeated human DNA clones. J Mol Biol (1981) 7.94
Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase. Proc Natl Acad Sci U S A (1983) 5.50
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A (1997) 4.20
Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. Proc Natl Acad Sci U S A (1984) 3.53
Isolation of a genomic clone partially encoding human hypoxanthine phosphoribosyltransferase. Proc Natl Acad Sci U S A (1982) 3.49
A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRT. Proc Natl Acad Sci U S A (1983) 3.31
Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry (1993) 3.26
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology (2008) 2.80
Fatigue in primary care: prevalence, psychiatric comorbidity, illness behavior, and outcome. J Gen Intern Med (1992) 2.79
Expression of a retrovirus encoding human HPRT in mice. Science (1984) 2.48
Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J Biol Chem (1999) 2.41
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology (2009) 2.37
Relationship of episiotomy to perineal trauma and morbidity, sexual dysfunction, and pelvic floor relaxation. Am J Obstet Gynecol (1994) 2.33
LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol (2000) 2.27
Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest (2001) 2.26
Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens. J Natl Cancer Inst (1998) 2.17
Skin lesions during intravenous hyperalimentation: zinc deficiency. 1976. Nutrition (1992) 2.03
Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J Virol (1996) 2.01
Symptom attribution in cultural perspective. Can J Psychiatry (1994) 1.98
A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem (1999) 1.98
Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J Neurosurg (1995) 1.94
Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J (1995) 1.94
Lamin B distribution and association with peripheral chromatin revealed by optical sectioning and electron microscopy tomography. J Cell Biol (1993) 1.92
Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc Natl Acad Sci U S A (2001) 1.90
Gene expression from transcriptionally disabled retroviral vectors. Proc Natl Acad Sci U S A (1987) 1.89
Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res (2001) 1.87
Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes. Diabetes (1991) 1.75
The organization of the human HPRT gene. Nucleic Acids Res (1986) 1.75
Elements in the long terminal repeat of murine retroviruses enhance stable transformation by thymidine kinase gene. Nucleic Acids Res (1983) 1.63
Variable stability of a selectable provirus after retroviral vector gene transfer into human cells. Mol Cell Biol (1986) 1.62
Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci U S A (1991) 1.61
Spondylo-meta-epiphyseal dysplasia (SMED), short limb-hand type: a congenital familial skeletal dysplasia with distinctive features and histopathology. Am J Med Genet (1993) 1.60
Geleophysic dysplasia: a storage disorder affecting the skin, bone, liver, heart, and trachea. J Pediatr (1990) 1.58
Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol (1999) 1.58
Patients who somatize in primary care: a longitudinal study of cognitive and social characteristics. Psychol Med (1996) 1.48
Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J Clin Invest (1999) 1.46
Influence of cell polarity on retrovirus-mediated gene transfer to differentiated human airway epithelia. J Virol (1998) 1.46
Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J Immunol (1996) 1.43
Molecular cloning and expression of a chloride ion channel of cell nuclei. J Biol Chem (1997) 1.41
Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism (1984) 1.41
A region in the steroid binding domain determines formation of the non-DNA-binding, 9 S glucocorticoid receptor complex. J Biol Chem (1988) 1.41
A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. J Mol Cell Cardiol (1999) 1.41
Retroviral vector-mediated gene transfer into human hematopoietic progenitor cells. Science (1985) 1.39
Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci (1986) 1.39
Detyrosinated (Glu) microtubules are stabilized by an ATP-sensitive plus-end cap. J Cell Sci (2000) 1.38
Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. Proc Natl Acad Sci U S A (1999) 1.38
Nuclear RNA transcripts from Drosophila melanogaster ribosomal RNA genes containing introns. Nucleic Acids Res (1980) 1.38
Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem (2000) 1.36
Does episiotomy prevent perineal trauma and pelvic floor relaxation? Online J Curr Clin Trials (1992) 1.35
Physicians' beliefs and behaviour during a randomized controlled trial of episiotomy: consequences for women in their care. CMAJ (1995) 1.35
A role for mitogen-activated protein kinase in the spindle assembly checkpoint in XTC cells. J Cell Biol (1997) 1.33
Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism (1983) 1.32
Ligand-directed retroviral targeting of human breast cancer cells. Proc Natl Acad Sci U S A (1995) 1.32
Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors. J Virol (1999) 1.32
Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats. Mol Ther (2001) 1.31
Three forms of somatization in primary care: prevalence, co-occurrence, and sociodemographic characteristics. J Nerv Ment Dis (1991) 1.31
Treatment for a nondisease: the case of low blood pressure. Soc Sci Med (1982) 1.30
Axonal transport of adeno-associated viral vectors is serotype-dependent. Gene Ther (2012) 1.29
VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther (2000) 1.28
Superoxide dismutase activity of normal murine liver, regenerating liver, and H6 hepatoma. J Natl Cancer Inst (1978) 1.27
Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease. Neuroscience (2004) 1.27
FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation (1997) 1.26
Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain. Neuroreport (2001) 1.26
beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue. Mol Pharmacol (2000) 1.25
Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Behçet's disease. Am J Med (1985) 1.22
Distribution of AAV-TK following intracranial convection-enhanced delivery into rats. Cell Transplant (2000) 1.21
Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells. Genes Dev (1994) 1.20
Brachyolmia: radiographic and genetic evidence of heterogeneity. Am J Med Genet (1989) 1.20
An endogenous mouse mammary tumor virus genome common in inbred mouse strains is located on chromosome 6. J Virol (1986) 1.19
Increasing epithelial junction permeability enhances gene transfer to airway epithelia In vivo. Am J Respir Cell Mol Biol (2000) 1.18
A large family with features of pseudoachondroplasia and multiple epiphyseal dysplasia: exclusion of seven candidate gene loci that encode proteins of the cartilage extracellular matrix. Hum Genet (1994) 1.16
Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins. Gene Ther (2001) 1.16
6-[18F]fluoro-L-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primates. Brain Res (1997) 1.15
Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary. J Virol (2001) 1.14
Removal of MAP4 from microtubules in vivo produces no observable phenotype at the cellular level. J Cell Biol (1996) 1.13
A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors. Hum Gene Ther (2001) 1.11
Adenosine release from stimulated mast cells. Proc Natl Acad Sci U S A (1984) 1.11
Expression of molecular clones of v-myb in avian and mammalian cells independently of transformation. J Virol (1986) 1.10
A new autosomal recessive lethal chondrodystrophy with congenital hydrops. Am J Med Genet (1988) 1.10
In vitro generation and transplantation of precursor-derived human dopamine neurons. J Neurosci Res (2001) 1.09
Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes. J Biol Chem (2000) 1.09
Hypoglycaemic effect of AICAriboside in mice. Diabetologia (1996) 1.08
Three N-terminal domains of beta-1,3-glucanase A1 are involved in binding to insoluble beta-1,3-glucan. J Bacteriol (1992) 1.08
Economic burden of obesity-related chronic diseases in Mainland China. Obes Rev (2008) 1.08
Factors important to students in selecting a residency program. Acad Med (1990) 1.07
Partial phenotypic correction of human Lesch-Nyhan (hypoxanthine-guanine phosphoribosyltransferase-deficient) lymphoblasts with a transmissible retroviral vector. J Biol Chem (1984) 1.05
Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines. Br J Cancer (1997) 1.04
Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo. Bone (1996) 1.04
TRANK, a novel cytokine that activates NF-kappa B and c-Jun N-terminal kinase. J Immunol (1998) 1.04
3PO, a novel nonviral gene delivery system using engineered Ad5 penton proteins. Gene Ther (2001) 1.04
Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy. J Pharmacol Exp Ther (1999) 1.04
Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primates. J Virol (1994) 1.04
Possible heterogeneity in spondyloenchondrodysplasia: quadriparesis, basal ganglia calcifications, and chondrocyte inclusions. Am J Med Genet (1990) 1.03